GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site)
Financial Results:
Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q4FY25 of ₹974.00 Crores up from ₹930.00 Crore year on year, a rise of 4.73%.
Total Expenses for Q4FY25 of ₹657.00 Crores down from ₹692.00 Crores year on year, a fall of 5.06%.
Consolidated Net Profit of ₹263.00 Crores up 35.57% from ₹194.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹15.52, up 35.19% from ₹11.48 in the same quarter of the previous year.